INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 321
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Cuvo Health

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'The platform brands choose when they compare.' Revenue settles directly to the brand's merchant account; full patient data export anytime.

Audienceread

Med spas and DTC brands wanting transparent-cost white-label telehealth.

Pricing & termsverified

Launch $997/mo + $9,800 one-time setup; Grow $2,500/mo + $15,000 setup; Enterprise custom; $25 per consult; no revenue share.

Clinical relationshipspartial

50-state licensed providers (recruited, credentialed, insured by Cuvo), branded lab testing (Quest/Labcorp walk-in, Tasso at-home kits, nurse draws), patient software under the brand's name; GLP-1, HRT/TRT, peptides, sexual health, women's health categories.

Pharmacy & fulfillmentpartial

Licensed partner pharmacies with cold-chain home delivery; bring-your-own-pharmacy supported; no revenue share.

Advertising snapshotpartial

Google: No ads found for cuvo.co (US, last 30 days, 20 Oct 2026). Meta: Meta Ad Library keyword lookup for 'cuvo.co' returned no matching ads on 20 Oct 2026. LinkedIn: LinkedIn Ad Library returned 'No results found' on 20 Oct 2026.

Founding yearnot_found

Not established in this pass.

    Foundersnot_found

    Not established in this pass.

      Location & entity contextnot_found

      Not stated on pages reviewed.

        Search visibility samplenot_found

        Not assessed in this pass.

          THE MODERN DOSING WEEKLY

          The peptide news
          that changes your week.

          Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.